Recombinant Chicken TACSTD2
Cat.No. : | TACSTD2-5053C |
Product Overview : | Recombinant Chicken TACSTD2 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Chicken |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | TACSTD2 tumor-associated calcium signal transducer 2 [ Gallus gallus (chicken) ] |
Official Symbol : | TACSTD2 |
Gene ID : | 772378 |
Protein Refseq : | NP_001264605 |
Products Types
◆ Recombinant Protein | ||
TACSTD2-5568R | Recombinant Rat TACSTD2 Protein, His (Fc)-Avi-tagged | +Inquiry |
TACSTD2-10H | Active Recombinant Human TACSTD2 Protein (His27-Thr274), C-6×His tagged | +Inquiry |
TACSTD2-971R | Recombinant Rat TACSTD2 Protein (Met1-Gly270), His-tagged | +Inquiry |
Tacstd2-6273M | Recombinant Mouse Tacstd2 Protein, Myc/DDK-tagged | +Inquiry |
TACSTD2-1027R | Recombinant Rhesus TACSTD2 Protein (Met1-Arg272), His-tagged | +Inquiry |
◆ Lysates | ||
TACSTD2-2546HCL | Recombinant Human TACSTD2 cell lysate | +Inquiry |
TACSTD2-1630MCL | Recombinant Mouse TACSTD2 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionImmunohistochemistry and PCR-based assays are common techniques to measure TACSTD2 expression in cancer tissues.
TACSTD2 promotes cancer cell migration and invasion, leading to metastasis by interacting with various signaling pathways.
Yes, there are ongoing clinical trials testing TACSTD2-targeted therapies, including antibody-drug conjugates and immunotherapies.
Common side effects can include fatigue, nausea, diarrhea, and skin rashes, similar to other cancer treatments.
Yes, monoclonal antibodies and antibody-drug conjugates targeting TACSTD2 are being investigated for cancer treatment.
Customer Reviews (3)
Write a reviewIn addition to its advantages in trials, the manufacturer of the TACSTD2 protein offers exceptional support to researchers.
Their team of technical experts possess deep knowledge and expertise regarding the protein, ensuring that researchers receive accurate and timely assistance.
the TACSTD2 protein has been extensively studied and validated in various experimental applications.
Ask a Question for All TACSTD2 Products
Required fields are marked with *
My Review for All TACSTD2 Products
Required fields are marked with *
Inquiry Basket